| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2025/02/28 | 21 : 59 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/02/28 | 21 : 01 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/02/24 | 20 : 08 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/02/19 | 20 : 56 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/02/18 | 22 : 13 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/02/18 | 21 : 59 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/02/10 | 21 : 25 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/02/10 | 21 : 17 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/01/28 | 20 : 33 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/01/24 | 22 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/01/22 | 22 : 02 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2025/01/21 | 20 : 35 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/12/31 | 22 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/10/31 | 21 : 48 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/10/23 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/10/15 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/10/04 | 19 : 26 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/10/02 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/09/30 | 19 : 20 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/09/27 | 05 : 40 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/09/27 | 05 : 33 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/09/27 | 05 : 32 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/09/20 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/09/03 | 19 : 03 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/08/01 | 20 : 06 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/07/24 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/07/19 | 19 : 31 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/07/19 | 19 : 22 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
| 2024/07/18 | 21 : 00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | USOTC:PRNAF | Alterity Therapeutics Ltd (PK) |
